Hypofractionated stereotactic body radiotherapy in patients with peripherally or centrally located medically inoperable stage I or isolated recurrent non-small cell lung cancer.

MLA

Chang, Joe Y., et al. “Hypofractionated Stereotactic Body Radiotherapy in Patients with Peripherally or Centrally Located Medically Inoperable Stage I or Isolated Recurrent Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology, vol. 2, Aug. 2007, p. S477. EBSCOhost, https://doi.org/10.1097/01.JTO.0000283432.89638.84.

APA

Chang, J. Y., Balter, P., Liao, Z., Bucci, K. M., Mcaleer, M. F., Yang, Q., Dong, L., Roth, J. A., Cox, J. D., & Komaki, R. (2007). Hypofractionated stereotactic body radiotherapy in patients with peripherally or centrally located medically inoperable stage I or isolated recurrent non-small cell lung cancer. Journal of Thoracic Oncology, 2, S477. https://doi.org/10.1097/01.JTO.0000283432.89638.84

Chicago

Chang, Joe Y., Peter Balter, Zhongxing Liao, Kara M. Bucci, Mary F. Mcaleer, Qiuan Yang, Lei Dong, Jack A. Roth, James D. Cox, and Ritsuko Komaki. 2007. “Hypofractionated Stereotactic Body Radiotherapy in Patients with Peripherally or Centrally Located Medically Inoperable Stage I or Isolated Recurrent Non-Small Cell Lung Cancer.” Journal of Thoracic Oncology 2 (August): S477. doi:10.1097/01.JTO.0000283432.89638.84.